Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2A | Q12879 | 2/20 | 0.68 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.68 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.66 |
| ▸ | CDC25A | P30304 | 3/20 | 0.61 |
| ▸ | POLA1 | P09884 | 1/20 | 0.60 |
| ▸ | NPC1L1 | Q9UHC9 | 3/20 | 0.57 |
| ▸ | OSBP | P22059 | 1/20 | 0.55 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.54 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.54 |
| ▸ | FNTA | P49354 | 1/20 | 0.54 |
| ▸ | FNTB | P49356 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18376473 | 1.00 | GRIN2A (0.68) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL20390519 | 1.00 | GRIN2A (0.68) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL25988189 | 0.94 | GRIN2A (0.72) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL25988186 | 0.94 | GRIN2A (0.72) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL23430466 | 0.92 | GRIN2A (0.67) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL18374274 | 0.92 | GRIN2A (0.67) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL21257681 | 0.92 | GRIN2A (0.67) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL18374275 | 0.92 | GRIN2A (0.67) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL18376878 | 0.91 | GRIN2A (0.68) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 | |
| SCHEMBL24709777 | 0.91 | GRIN2A (0.68) | GRIN2AGRIN1GRIN2BCYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637408-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-26 | — | — | US | disclosed |
| US-20260132353-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-14 | — | — | US | disclosed |
| US-12529007-B2 | Lipid comprising docosapentaenoic | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-01-20 | — | — | US | disclosed |
| US-12421472-B2 | Process for producing extracted lipid comprising docosahexaenoic acid | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION - (AU) | 2025-09-23 | — | — | US | disclosed |
| US-20240084214-A1 | LIPID COMPRISING POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2024-03-14 | — | — | US | disclosed |
| US-20230416186-A1 | LIPID COMPOSITIONS COMPRISING TRIACYLGLYCEROL WITH LONG-CHAIN POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-12-28 | — | — | US | disclosed |
| US-11834621-B2 | Lipid comprising polyunsaturated fatty acids | Nuseed Global Innovation Ltd. (GB) | 2023-12-05 | — | — | US | disclosed |
| US-11718577-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-08-08 | — | — | US | disclosed |
| US-20230219879-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-07-13 | — | — | US | disclosed |
| US-20220356414-A1 | PROCESS FOR PRODUCING EXTRACTED LIPID COMPRISING DOCOSAHEXAENOIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2022-11-10 | — | — | US | disclosed |
| US-20150045569-A1 | LIPID COMPRISING POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-02-12 | — | — | US | disclosed |
| US-8946460-B2 | Process for producing polyunsaturated fatty acids in an esterified form | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-02-03 | — | — | US | disclosed |
| US-8816111-B2 | Lipid comprising polyunsaturated fatty acids | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2014-08-26 | — | — | US | disclosed |
| US-20130338387-A1 | PROCESS FOR PRODUCING ETHYL ESTERS OF POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-12-19 | — | — | US | disclosed |
| WO-2013185184-A2 | PRODUCTION OF LONG CHAIN POLYUNSATURATED FATTY ACIDS IN PLANT CELLS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-12-19 | — | — | WO | disclosed |
| US-20130338388-A1 | LIPID COMPRISING POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-12-19 | — | — | US | disclosed |
| US-20130288318-A1 | HIGH OLEIC ACID OILS | GRAINS RESEARCH AND DEVELOPMENT CORPORATION (AU) | 2013-10-31 | — | — | US | disclosed |
| WO-2013159149-A1 | HIGH OLEIC ACID OILS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-10-31 | — | — | WO | disclosed |
| EP-0871451-A1 | STANOL COMPOSITION AND THE USE THEREOF | Raisio Benecol Ltd. (FI) | 1998-10-21 | — | — | EP | disclosed |
| WO-1998006405-A1 | STANOL COMPOSITION AND THE USE THEREOF | RAISIO BENECOL LTD. (FI) | 1998-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637408-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | SCD, ELOVL3, DAGLA | GRIN2A 1092/4885GRIN1 1798/4885GRIN2B 3017/4885 |
| US-12529007-B2 | Lipid comprising docosapentaenoic | DAGLA, SCD, FADS2 | GRIN2A 2038/4885GRIN1 2206/4885GRIN2B 3828/4885 |
| US-20260132353-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | ELOVL3, SCD, ELOVL6 | GRIN2A 2216/4885GRIN1 2261/4885GRIN2B 3746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.